Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Canadians have better access to medications, providing an alternative for those seeking treatment
Recommend 100% Great product Gives my body what I need I really like it and I really like how I feel with it
Wegovy has a list price of $1,349 per month without insurance
ALSO READ : Retatrutide not registered with Drug Control Authority A doctor, speaking on condition of anonymity, warned that the Reta Pens sold locally could very well be counterfeit products
Trajenta (Linagliptin/Metformin) Trajenta 2022 sales: $1.846 billion Company/Developer: Boehringer Ingelheim and Eli Lilly Date of first FDA approval: May 2, 2021 Indications Trajenta is FDA-approved for: Trajenta serves as a DPP-4 inhibitor, prescribed as a supplementary measure alongside diet and exercise to enhance glycemic control in adults diagnosed with type 2 diabetes mellitus
US$ 27.81
US$ 26.30
US$ 25.70
US$ 23.33
